It has been shown in another study that plumbagin has anti-fibrotic action by inhibiting the NF-kβ/TLR-4 pathway, which is linked to inflammatory responses, and therefore reducing liver fibrosis [192]. This evidence concerns the gene TLR4 and Hepatic fibrosis.